Limb-girdle muscular dystrophy type 2I (LGMD2I) is an autosomal recessive muscular dystrophy caused by mutations in the
FKRP gene.
1FKRP encodes a putative Golgi-resident glycosyltransferase fukutin-related protein that is involved in α-dystroglycan glycosylation.
1,2 Missense, nonsense, and insertion and deletion mutations have been reported in the 1.5-kilobase (kb) coding exon of
FKRP in large series of patients with limb-girdle muscular dystrophies.
1,3-8 Most of the
FKRP mutations are rare, but the 826C>A mutation is common.
1,3,4,6,7,9 The clinical phenotype in LGMD2I is heterogeneous, including asymptomatic
FKRP mutation carriers,
6 patients with a severe early-onset type of Duchenne muscular dystrophy, and patients with mild late-onset muscular dystrophy with slow progression. Dilated cardiomyopathy and severe restrictive respiratory insufficiency have been reported in several, but not all, patients with LGMD2I.
1,3-7,10 The emerging pattern of muscle involvement in LGMD2I includes proximal distribution of weakness in the limbs, with the hips more affected than the shoulders.
3 Muscle hypertrophy is common, including the calves and, occasionally, other muscles.
FKRP mutations have also been reported in a severe form of congenital muscular dystrophy (MDC1C)
11 and in congenital muscular dystrophy complicated by structural brain abnormalities (a complete list of
FKRP mutations is available at: http://www.dmd.nl).